KYMR
NASDAQ · Biotechnology
Kymera Therapeutics Inc
$127.87
-8.38 (-6.15%)
Earnings Summary
Beats (Last 1)
0/1
Avg Surprise
-18.6%
Latest EPS
$-0.97
History
1 quarter
Earnings History
| Date | Quarter | EPS Est | EPS Actual | Surprise | Surprise % | Result |
|---|---|---|---|---|---|---|
| Oct 29, 2026 | Q4 FY2026 | $-1.29 | — | — | — | — |
| Aug 10, 2026 | Q3 FY2026 | $-0.73 | — | — | — | — |
| Apr 30, 2026 | Q2 FY2026 | $-0.90 | — | — | — | — |
| Feb 26, 2026 | Q1 FY2026 | $-0.82 | $-0.97 | -$0.15 | -18.6% | Miss |
| Feb 19, 2026 | Q1 FY2026 | $-0.82 | — | — | — | — |